下一代测序技术引领下的血液系统恶性肿瘤研究新进展：第55届美国血液学会年会报道

第55届美国血液学会（ASH）年会最大亮点是在下一代测序技术（NGS）引领下,血液系统恶性肿瘤诊断、发病机制、疗效评价、预后分析和微小残留病（MRD）监测等领域出现一系列革命性进步.文章仅将第55届Best ASH中应用NGS技术取得重要突破的7篇论文介绍给国内读者.

Next generation of sequencing techniques guide the new progress of malignant blood diseases: reports in the 55th ASH annual meeting

The biggest highlight in the 55th ASH annual meeting is a series of revolutionary progress in the field of diagnosis, pathogenesis, prediction, prognosis and minimal residue disease (MRD) of malignant blood diseases guiding with next generation of sequencing (NGS) techniques. This article will share the major contents of 7 papers using NGS techniques in the ASH annual meeting with domestic readers here.